Family Office · Oslo, Norway
Inven2 is a Norwegian technology transfer company based in Oslo, established in 2010 as a subsidiary of the University of Oslo and Oslo University Hospital. The company specializes in commercializing research and innovation, managing intellectual property, and facilitating the development of start-ups and licensing agreements in the life sciences and health sectors. Inven2 is recognized as one of the largest technology transfer offices in Norway, supporting researchers and clinicians in bringing scientific discoveries to market. The company has contributed to the creation of numerous start-ups and has played a significant role in advancing medical and biotech innovations in the Nordic region.
Business models
biotech_therapeutics, deeptech_ip, saas_b2b, platform, hardware
Customer segments
Enterprise, Healthcare providers, Hospitals, Researchers
Geography
Norway, Europe
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Inven2 deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VC Boom tracks Inven2 alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
4Bio Capital
advanced therapies, life sciences, gene therapy
Seed VC
4BIO Capital
advanced therapies, gene therapy, life sciences
Seed VC
Advice Capital
biotech, global equities
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Family Office
AGEM Property Group
commercial real estate, childcare, medical
Seed VC
AgFunder
agrifoodtech, AI, biotech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Inven2 is one of them — and we'll tell you exactly where they sit in your top 100.